Pen Needles Market Size is Expected to Worth of US$ 9.48 Bn in 2032

The global pen needles market size was estimated at USD 3.50 billion in 2023 and is expected to hit around USD 9.48 billion by 2032 with a CAGR of 11.70% from 2023 to 2032.

Key Takeaways

  • Europe contributed more than 38% of revenue share in 2022.
  • Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By product, the standard segment has held the largest market share of 87% in 2022.
  • By product, the safety pen needles segment is anticipated to grow at a remarkable CAGR of 13.1% between 2023 and 2032.
  • By needle length, the 8mm segment generated over 35% of revenue share in 2022.
  • By needle length, the 4mm segment is expected to expand at the fastest CAGR over the projected period.
  • By therapy, the insulin therapy segment generated over 78% of revenue share in 2022.
  • By therapy, the glucagon-like-peptide-1 segment is expected to expand at the fastest CAGR over the projected period.

The Pen Needles Market is a dynamic sector within the healthcare industry that revolves around the production and distribution of pen needles, crucial components in the field of insulin delivery. These devices have significantly improved the quality of life for individuals with diabetes, offering a convenient and efficient method of administering insulin. As the prevalence of diabetes continues to rise globally, the demand for pen needles is witnessing a substantial surge.

Pen Needles Market Size 2023 To 2032

Growth Factors:

Several factors contribute to the growth of the Pen Needles Market. The increasing incidence of diabetes, coupled with a growing awareness of the benefits associated with pen needles, is a primary driver. Technological advancements leading to the development of more user-friendly and innovative pen needle products also fuel market expansion. Moreover, the emphasis on self-administration of insulin and the rising geriatric population contribute significantly to the market’s upward trajectory.

Get a Sample:


The Pen Needles Market presents numerous opportunities for expansion and diversification. One key opportunity lies in the untapped markets, especially in developing regions where diabetes prevalence is on the rise. Collaborations and partnerships between healthcare providers and manufacturers can open new avenues for product development and market penetration. Additionally, the integration of smart technologies into pen needle devices offers a promising frontier, allowing for enhanced patient monitoring and data management.


Despite the promising growth, the Pen Needles Market faces certain challenges. Stringent regulatory requirements and approval processes can impede the introduction of new products, leading to a slower pace of innovation. Price competition among market players may also pose a challenge, particularly in cost-sensitive markets. Furthermore, the need for proper disposal and environmental concerns related to plastic waste generated by pen needles adds to the challenges that industry stakeholders must navigate.

Pen Needles Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 11.70%
Market Size in 2023 USD 3.50 Billion
Market Size by 2032 USD 9.48 Billion
Largest Market Europe
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Product, By Needle Length, By Therapy
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

By Product:

Insulin Pen Needles: Insulin pen needles are a fundamental product category, integral to the daily lives of individuals managing diabetes. They come in various lengths and gauges to accommodate different insulin formulations and patient preferences.

Safety Pen Needles: Safety pen needles emphasize enhanced safety features to minimize the risk of needlestick injuries. This product category is gaining popularity among healthcare professionals and patients, contributing to a safer injection experience.

Standard Pen Needles: Standard pen needles represent the traditional and widely used category designed for regular insulin injections. They offer a cost-effective and straightforward solution for patients who prioritize simplicity.

Nano Pen Needles: Nano pen needles are characterized by their ultra-fine and short needle lengths. This product category caters to individuals seeking a less invasive and more comfortable injection experience, particularly those with needle anxiety or sensitivity.

By Needle Length:

Short Needle Lengths: Short needle lengths are often associated with nano pen needles, providing a less invasive injection experience. They are favored by individuals who prefer minimal needle penetration for various medical conditions.

Medium Needle Lengths: Medium needle lengths are versatile and commonly used across different pen needle categories. They offer a balance between ease of use and injection depth, catering to a broad range of patient needs.

Long Needle Lengths: Long needle lengths may be associated with specific therapeutic requirements. They are designed to penetrate deeper for effective drug delivery, and their use depends on the prescribed therapy and patient characteristics.

By Therapy:

Diabetes: The diabetes segment dominates the pen needles market, encompassing insulin pen needles and various needle lengths. The focus is on providing effective and convenient solutions for insulin delivery to individuals managing diabetes.

Growth Hormone Therapy: Pen needles play a crucial role in growth hormone therapy, delivering precise doses for patients with growth hormone deficiencies. This segment reflects the versatility of pen needles in addressing diverse medical needs.

Other Therapies: Beyond diabetes and growth hormone therapy, pen needles are employed in various medical conditions requiring subcutaneous injections. This includes but is not limited to the administration of other hormones, biologics, and medications for different therapeutic purposes.

Read Also: Robotic Dentistry Market Size To Worth USD 1,714.14 Million By 2032

Recent Developments

  • Roche Diabetic Care introduced pen needles featuring ACCU-FINE technology, emphasizing painless insulin administration. This technological advancement aligns with the industry’s continuous efforts to enhance patient comfort and compliance in insulin delivery, marking a notable contribution to the evolving landscape of diabetes management. Both announcements highlight the ongoing efforts within the market to bring forth cutting-edge solutions for more effective and patient-friendly insulin administration.

Pen Needles Market Players

  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Ypsomed AG
  • Owen Mumford Ltd.
  • Terumo Corporation
  • Allison Medical, Inc.
  • Artsana S.p.A.
  • Trividia Health, Inc.
  • Perrigo Company plc
  • B. Braun Melsungen AG
  • UltiMed, Inc.
  • Simple Diagnostics
  • Arkray, Inc.
  • GlucoRx Ltd.

Segments Covered in the Report

By Product

  • Standard Pen Needles
  • Safety Pen Needles

By Needle Length

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 10 mm
  • 12 mm

By Therapy

  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333







Fabio Thomas 

Fabio Thomas 

Fabio is a Senior Editor at Reports Gazette who focused on healthcare it news. Also, he is a writer and public health researcher.  He joins Reports Gazette from Modern Healthcare, where he worked as a web producer since 2020. Before joining the Modern Healthcare team, Fabio received a master’s degree in journalism from Northwestern University. He is the author of a 2016-17 book, he is also the recipient of numerous awards.

View all posts by Fabio Thomas  →

Leave a Reply

Your email address will not be published. Required fields are marked *